Abstract
A 69-year-old man diagnosed as having gallbladder cancer with liver invasion and metastasis to Couinaud’s hepatic segment 8 (S8) was referred to our hospital. Because of the presence of liver metastasis, gemcitabine administration was chosen. Although gemcitabine was effective for the liver metastasis, his serum carcinoembryonic antigen (CEA) level had gradually increased after 12 cycles of gemcitabine administration. There was no distant metastasis other than the liver metastasis (manageable with gemcitabine) on detailed radiological examination. Therefore, we performed surgery for the primary lesion, after obtaining informed consent. Pathological examination demonstrated viable cancer cells with necrosis and fibrosis in the gallbladder, and fibrosis without viable cancer cells in the induration in liver S8. Gemcitabine was re-administered as postoperative adjuvant chemotherapy. Twenty months after the surgery, there was no sign of recurrence. In selected patients, gemcitabine treatment may be effective against gallbladder cancer with metastasis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Glimelius B, Hoffman K, Sjödén PO, Jacobsson G, Sellström H, Enander LK, et al. Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer. Ann Oncol 1996;7:593–600.
Ishikawa T, Horimi T, Shima Y, Okabayashi T, Nishioka Y, Hamada M, et al. Evaluation of aggressive surgical treatment for advanced carcinoma of the gallbladder. J Hepatobiliary Pancreat Surg 2003;10:233–238.
National Cancer Institute. Common toxicity criteria (version 2). Bethesda: Division of Cancer Treatment and Diagnosis, National Cancer Institute, 1999.
Glimelius B. Chemotherapy in the treatment of cancer of the pancreas. J Hepatobiliary Pancreat Surg 1998;5:235–241.
Fung MC, Sakata T. What’s new in pancreatic cancer treatment? J Hepatobiliary Pancreat Surg 2002;9:61–75.
Mita Y, Ajiki T, Kamigaki T, Okazaki T, Hori H, Horiuchi H, et al. Antitumor effect of gemcitabine on orthotopically inoculated human gallbladder cancer cells in nude mice. Ann Surg Oncol 2007;14:1374–1380.
Okusaka T, Ishii H, Funakoshi A, Yamao K, Ohkawa S, Saito S, et al. Phase II study of single-agent gemcitabine in patients with advanced biliary tract cancer. Cancer Chemother Pharmacol 2006;57:647–653.
Sugita H, Hirota M, Ichihara A, Furuhashi S, Kihara S, Shimada S. Combined chemotherapy of irinotecan and low-dose cisplatin (I/low-P) against metastatic biliary tract cancer. J Hepatobiliary Pancreat Surg 2006;13:463–467.
Takahashi I, Kakeji Y, Emi Y, Sakurai M, Yonemura Y, Kimura Y, et al. S-1 in the treatment of advanced and recurrent gastric cancer: current state and future prospects. Gastric Cancer 2003;6:28–33.
Aretxabala X, Roa I, Berrios M, Hepp J, Gallardo J, Cordova A, et al. Chemoradiotherapy in gallbladder cancer. J Surg Oncol 2006;93:699–704.
McMasters KM, Tuttle TM, Leach SD, Rich T, Cleary KR, Evans DB, et al. Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma. Am J Surg 1997;174:605–609.
Author information
Authors and Affiliations
About this article
Cite this article
Morimoto, H., Ajiki, T., Takase, S. et al. Resection of gallbladder cancer with hepatic metastasis after chemotherapy with gemcitabine. J Hepatobiliary Pancreat Surg 15, 655–658 (2008). https://doi.org/10.1007/s00534-007-1311-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00534-007-1311-9